ROSELLA: A study of relacorilant in combination with nab-paclitaxel in platinum resistant ovarian cancer
Researchers in this trial are trying to find better ways of treating platinum-resistant ovarian cancer. Platinum resistance means your cancer no longer responds to platinum-based chemotherapy (e.g. carboplatin). Strong evidence suggests that cortisol, a hormone in your body, can affect how well certain cancer treatments work. Scientists have fou…